Cargando…
Engineered Synthetic STxB for Enhanced Cytosolic Delivery
Many molecular targets for cancer therapy are located in the cytosol. Therapeutic macromolecules are generally not able to spontaneously translocate across membranes to reach these cytosolic targets. Therefore a strong need exists for tools that enhance cytosolic delivery. Shiga toxin B-subunit (STx...
Autores principales: | Hadjerci, Justine, Billet, Anne, Kessler, Pascal, Mourier, Gilles, Ghazarian, Marine, Gonzalez, Anthony, Wunder, Christian, Mabrouk, Nesrine, Tartour, Eric, Servent, Denis, Johannes, Ludger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177378/ https://www.ncbi.nlm.nih.gov/pubmed/37174690 http://dx.doi.org/10.3390/cells12091291 |
Ejemplares similares
-
STxB as an Antigen Delivery Tool for Mucosal Vaccination
por: Tartour, Eric, et al.
Publicado: (2022) -
Absolute Quantification of Drug Vector Delivery to the Cytosol
por: Lucchino, Marco, et al.
Publicado: (2021) -
Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds
por: Stimmer, Lev, et al.
Publicado: (2014) -
Preparation of chitosan nanoparticle containing recombinant StxB antigen of EHEC and evaluation its immunogenicity in BALB/c mice
por: Almasian, Pegah, et al.
Publicado: (2018) -
An in silico Design, Expression and Purification of a Chimeric Protein as an Immunogen Candidate Consisting of IpaD, StxB, and TolC Proteins from Shigella spp.
por: Fathi, Javad, et al.
Publicado: (2022)